Moderna stock falls 8% after report says late-stage coronavirus vaccine trial delayed

Moderna stock falls 8% after report says late-stage coronavirus vaccine trial delayed

Moderna’s stock fell 8% on Thursday after a report said the biotech company’s late-stage trial for a potential coronavirus vaccine will be delayed, possibly by a few weeks. The company, which is working with the National Institutes of Health, was expected to begin a phase 3 trial with 30,000 participants for its vaccine candidate later this month, […]